शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSEEverest Organics Ltd· Pharmaceuticals & BiotechnologyHighNeutral
Announced Tue, 5 Aug, 2025 · 15:55 IST

Everest Organics Limited submitted Unaudited Financial Results for quarter ended June 30, 2025

Revenue growth above 20%Profit growth above 25%EBITDA margin expansionQualified audit opinionGoing-concern doubtResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.0%Reaction day
₹320.50
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.1%+1.1% vs market
Pharmaceuticals peers, median of 149sector-1.7%+1.7% vs sector

On the reaction day the stock moved 1.1 pts more than Nifty Microcap 250 and 1.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.0-1.1+1.1-1.7+1.7
Next day
-1.0-1.4+0.4-1.5+0.5
2d
—-2.2—-2.0—
3d
-5.9-2.0-3.9-2.0-3.9
4d
-1.2-2.0+0.8-1.8+0.6
5d
+3.7-1.4+5.1-1.8+5.5
1w
+14.3-0.7+15.0-2.1+16.4
15d
+23.1-2.5+25.7-3.6+26.7
1m
+25.3+0.3+25.0-2.6+27.8
2m
+21.7-0.7+22.3-3.5+25.2
3m
+24.0-0.6+24.6-5.7+29.7
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 149Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Everest Organics reported a strong Q1 FY26 with revenue from operations at ₹5,381.32 lakhs, up 65.8% YoY from ₹3,244.59 lakhs in Q1 FY25. Total income rose to ₹5,436.28 lakhs. The company swung back to profit with PAT of ₹140.52 lakhs versus a loss of ₹(608.96) lakhs a year ago, and EPS of ₹1.45 vs ₹(7.61). For FY25, revenue stood at ₹15,947.90 lakhs with a loss of ₹(129.03) lakhs. Domestic sales contributed ₹4,215.33 lakhs and exports ₹1,165.99 lakhs. However, the statutory auditor issued a qualified review report flagging that the company is operating at enhanced production capacity without proper approvals from the Telangana State Pollution Control Board (TSPCB), which could attract a closure order and impact going concern status.

Likely market impact

The sharp revenue rebound and return to profitability are positive for shareholders, but the auditor's qualification on TSPCB compliance and the explicit going concern risk tied to a possible closure order pose a significant regulatory overhang that investors should monitor closely.